Lower CSF Aβ42 | Higher CSF Aβ42 | p-value | |
---|---|---|---|
n (M/F) | 8 (3/5) | 17 (9/8) | 0.673 |
Age, yr | 76.1 ± 7.3 | 72.0 ± 6.7 | 0.187 |
Education, yr | 7.7 ± 5.6 | 8.7 ± 5.2 | 0.687 |
K-MMSE | 16.8 ± 6.6 | 20.8 ± 6.9 | 0.193 |
Disease duration, day | 724.1 ± 513.6 | 769.4 ± 520.4 | 0.857 |
Aβ42, pg/ml | 368.7 ± 72.3 | 679.1 ± 121.7 | <0.001* |
T-tau, pg/ml | 145.7 ± 103.9 | 125.3 ± 64.6 | 0.551 |
P-tau, pg/ml | 28.2 ± 13.8 | 26.4 ± 7.3 | 0.682 |
Evans ratio | 0.34 ± 0.02 | 0.36 ± 0.03 | 0.277 |
DWMH | 1.6 ± 0.9 | 1.5 ± 0.8 | 0.804 |
PVWMH | 2.0 ± 0.7 | 1.9 ± 0.7 | 0.856 |
Hippocampal atrophy | 1.6 ± 0.9 | 0.7 ± 0.6 | 0.020* |
Pre-gait score | 2.75 ± 1.48 | 2.59 ± 1.54 | 0.807 |
Pre-urinary score | 1.00 ± 1.06 | 0.94 ± 0.96 | 0.892 |
Pre-cognition score | 1.50 ± 0.75 | 1.41 ± 0.79 | 0.795 |
Pre-iNPH score sum | 4.13 ± 2.94 | 3.94 ± 2.86 | 0.883 |
Post-gait score | 2.00 ± 1.69 | 2.00 ± 1.11 | 1.000 |
Post-urinary score | 0.63 ± 1.06 | 0.47 ± 0.80 | 0.689 |
Post-cognition score | 1.38 ± 0.91 | 1.12 ± 0.78 | 0.474 |
Post-iNPH score sum | 3.00 ± 3.38 | 2.65 ± 2.14 | 0.753 |
Gait score improvement | 0.75 ± 0.70 | 0.59 ± 0.87 | 0.651 |
Urinary score improvement | 0.38 ± 0.74 | 0.47 ± 0.71 | 0.761 |
Cognition score improvement | 0.13 ± 0.35 | 0.29 ± 0.47 | 0.377 |
iNPH score improvement | 1.25 ± 1.48 | 1.29 ± 0.68 | 0.950 |